Wanbangde Pharmaceutical Holding Group Co., Ltd. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was CNY 429.17 million compared to CNY 385.23 million a year ago. Net income was CNY 28.84 million compared to CNY 27.34 million a year ago.

Basic earnings per share from continuing operations was CNY 0.0466 compared to CNY 0.0442 a year ago. Diluted earnings per share from continuing operations was CNY 0.0466 compared to CNY 0.0442 a year ago.